Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120)
NCT03336502
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
70
Enrollment
INDUSTRY
Sponsor class
Conditions
Fungal Infection
Interventions
DRUG:
Posaconazole
Sponsor
Merck Sharp & Dohme LLC